Specifically, they report that about 20% of ER+/HER2− breast cancers in the METABRIC [28] dataset harbor a shallow NF1 deletion (−1 copy number) correlating with poorer RFS and disease-specific survival [21]. The gene discussed is NF1; the disease is breast carcinoma.